UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009468
Receipt number R000011068
Scientific Title Effect of Febuxostat on vascular function in patients with hyperuricemia
Date of disclosure of the study information 2012/12/04
Last modified on 2021/03/30 16:49:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Febuxostat on vascular function in patients with hyperuricemia

Acronym

Effect of Febuxostat on vascular function in patients with hyperuricemia

Scientific Title

Effect of Febuxostat on vascular function in patients with hyperuricemia

Scientific Title:Acronym

Effect of Febuxostat on vascular function in patients with hyperuricemia

Region

Japan


Condition

Condition

hyperuricemia

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Febuxostat, a uric acid synthesis inhibitor, or Benzbromarone, a uricosuric drug, is administered to hyperuricemic patients (serum uric acid is greater than 8.0mg/dL with hypertension, ischemic heart disease, diabetes mellitus or metabolic syndrome, or serum uric acid is greater than 9.0mg/dL). After the serum uric acid level is controlled to 6.0mg/dL or less with these drugs, RHI (Reactive hyperemia index) by EndoPAT, an indicator of vascular function, and various biomarkers, such as ADMA, von Willebrand factor, endothelin-1, and VCAM-1 are measured in the patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of RHI measured by EndoPAT

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Febuxostat

Interventions/Control_2

Benzbromarone

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Hyperuricemia patients who meet the following criteria are enrolled;
1)Serum uric acid is greater than 8.0mg/dL with hypertension, ischemic heart disease, diabetes mellitus or metabolic syndrome, or serum uric acid is greater than 9.0mg/dL
2)Patients are required to the treatment of hyperuricemia
3)Age > 40 years
4)Patients agree to participate in this study.

Key exclusion criteria

The patients who meet the following criteria are excluded;
1)Patients will not take Febuxostat or Benzbromarone more than three months.
2)Frequent changes of concomitant medications are expected.
3)Patients with severe renal failure(eGFR<30 mL/min/1.73m2) and/ or on dialysis.
4)Pregnant woman
5)Patients have problems of severe allergic diseases on clinical course, or have a history of serious side effects and/or hypersensitivity to these drugs.
6)The physician judges that patients are inappropriate to attend this study.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Koji
Middle name
Last name Memura

Organization

Nagasaki University Graduate School of Biomedical Sciences

Division name

Department of Cardiovascular Medicine

Zip code

852-8501

Address

1-7-1 Sakamoto Nagasaki Japan

TEL

095-819-7288

Email

uminchu-23-tomo@awa.bbiq.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Ikeda

Organization

Nagasaki University Graduate School of Biomedical Sciences

Division name

Department of Cardiovascular Medicine

Zip code

852-8501

Address

1-7-1 Sakamoto Nagasaki Japan

TEL

095-819-7288

Homepage URL


Email

uminchu-23-tomo@awa.bbiq.jp


Sponsor or person

Institute

Nagasaki University Graduate School of Biomedical Sciences
Department of Cardiovascular Medicine

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University Graduate School of Biomedical Sciences
Department of Cardiovascular Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University Graduate School of Biomedical Sciences

Address

1-7-1 Sakamoto Nagasaki Japan

Tel

095-819-7217

Email

mh_shomu@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 12 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 11 Month 26 Day

Date of IRB

2012 Year 11 Month 26 Day

Anticipated trial start date

2012 Year 12 Month 04 Day

Last follow-up date

2020 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 12 Month 03 Day

Last modified on

2021 Year 03 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011068


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name